IRIS
VERDOIA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.435
EU - Europa 3.049
AS - Asia 1.977
SA - Sud America 341
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 43
OC - Oceania 4
Totale 9.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.343
RU - Federazione Russa 810
IE - Irlanda 650
SG - Singapore 559
CN - Cina 521
DE - Germania 481
SE - Svezia 336
HK - Hong Kong 307
VN - Vietnam 288
UA - Ucraina 260
BR - Brasile 250
FR - Francia 151
IN - India 132
IT - Italia 100
FI - Finlandia 84
GB - Regno Unito 74
CA - Canada 40
MX - Messico 35
AR - Argentina 33
IR - Iran 33
PL - Polonia 28
ID - Indonesia 27
BD - Bangladesh 22
ZA - Sudafrica 18
NL - Olanda 17
EC - Ecuador 16
ES - Italia 15
JP - Giappone 15
IQ - Iraq 14
PY - Paraguay 12
CO - Colombia 10
CZ - Repubblica Ceca 9
KR - Corea 9
AT - Austria 8
TR - Turchia 8
VE - Venezuela 8
LT - Lituania 7
UZ - Uzbekistan 7
JM - Giamaica 6
CL - Cile 5
MA - Marocco 5
PH - Filippine 5
UY - Uruguay 5
BE - Belgio 4
DZ - Algeria 4
EG - Egitto 4
PK - Pakistan 4
AU - Australia 3
EU - Europa 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CR - Costa Rica 2
NG - Nigeria 2
OM - Oman 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.853
Salva come PNG Salva come JPEG
Città #
Dublin 650
Jacksonville 504
San Jose 410
Hong Kong 307
Dearborn 248
Ashburn 212
Singapore 209
Wilmington 168
Beijing 160
Council Bluffs 159
Moscow 120
Columbus 100
Chandler 97
Lawrence 86
Princeton 86
Los Angeles 81
Bremen 80
Lauterbourg 78
Ho Chi Minh City 72
Hanoi 56
New York 43
Düsseldorf 41
Santa Clara 38
San Mateo 37
São Paulo 35
Buffalo 34
Orem 30
Redondo Beach 28
Ann Arbor 23
Munich 23
Dong Ket 20
Frankfurt am Main 20
Denver 19
Mexico City 19
Warsaw 19
Woodbridge 19
Haiphong 18
Houston 18
Leawood 18
Andover 17
Monmouth Junction 17
Chennai 15
Hefei 15
Nanjing 15
Dallas 14
Guangzhou 14
Johannesburg 14
Manchester 14
Norwalk 14
Poplar 14
Tokyo 14
Ardabil 13
Bexley 13
Chicago 13
Helsinki 13
Kunming 13
Piemonte 13
Torino 13
Brooklyn 12
Phoenix 12
Fairfield 11
Montreal 11
Seattle 11
Tianjin 11
Toronto 11
Biên Hòa 10
Augusta 9
Brno 9
Hangzhou 9
Seoul 9
Stockholm 9
Zanjan 9
Amsterdam 8
Atlanta 8
Da Nang 8
Jakarta 8
Jinan 8
New Delhi 8
Nuremberg 8
Novara 7
San Francisco 7
Shenyang 7
Tashkent 7
Belo Horizonte 6
Boston 6
London 6
Mumbai 6
Quito 6
Sacramento 6
Shenzhen 6
Turku 6
Ankara 5
Baghdad 5
Guayaquil 5
Hải Dương 5
Kingston 5
Manaus 5
Montevideo 5
Ottawa 5
Thái Bình 5
Totale 4.973
Salva come PNG Salva come JPEG
Nome #
Modulation of 1,25(OH)2D levels in cardiovascular system. Genetic regulation, impact on coronary artery disease, inflammation, platelet function and periprocedural myocardial injury after percutaneous coronary interventions 179
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 151
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 140
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 139
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 133
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 132
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 130
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 128
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 127
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 127
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 125
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 124
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 123
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 123
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 122
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 121
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 121
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 120
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 119
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 119
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 119
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 119
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 119
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 118
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 118
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 117
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 117
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 116
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 115
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 115
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 114
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 113
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 113
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 112
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 111
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 110
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 109
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 109
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 106
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 106
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 106
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 106
Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization. 105
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 105
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 104
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 102
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 102
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 100
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 100
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 99
Immature platelet fraction and the extent of coronary artery disease: A single centre study 99
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 99
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 98
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 98
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 98
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 97
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 96
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 95
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 91
Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease 91
Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy 89
Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study 89
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 88
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies. 86
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 85
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 85
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. 83
Statins and elderly: From clinical trials to daily practice 83
Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study. 82
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy 82
Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment 82
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 81
Two catheters for one perforation 80
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis 78
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 77
Impact of aging on immature platelet count and its relationship with coronary artery disease 76
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy 72
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 71
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study. 71
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents 70
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention 70
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve 69
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease 68
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention 68
Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation 65
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI 64
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort study 60
Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials 55
Targeted therapies in non–small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management 32
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management 31
Totale 9.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022479 0 40 38 34 47 7 15 13 32 29 105 119
2022/20231.278 92 52 85 6 108 107 25 85 645 3 45 25
2023/2024448 30 40 35 6 69 0 48 7 1 4 142 66
2024/2025739 23 15 23 2 41 5 81 128 189 73 10 149
2025/20263.596 168 120 273 603 302 258 629 612 188 224 156 63
2026/2027366 135 231 0 0 0 0 0 0 0 0 0 0
Totale 9.062